HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

NCT06634420 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema

Interventions

BIOLOGICAL: NTLA-2002
BIOLOGICAL: Normal Saline IV Administration

Sponsor

Intellia Therapeutics